Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis

Ocana Noronha, Lucia Mesarosovo, Jasper J. Anink, Anand Iyer, Eleonora Aronica, James D. Mills

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)


To date, no neurodegenerative diseases (NDDs) have cures, and the underlying mechanism of their pathogenesis is undetermined. As miRNAs extensively regulate all biological processes and are crucial regulators of healthy brain function, miRNAs differentially expressed in NDDs may provide insight into the factors that contribute to the emergence of protein inclusions and the propagation of deleterious cellular environments. A meta-analysis of miRNAs dysregulated in Alzheimer’s disease, Parkinson’s disease, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, dementia with Lewy bodies and frontotemporal lobar degeneration (TDP43 variant) was performed to determine if diseases within a proteinopathy have distinct or shared mechanisms of action leading to neuronal death, and if proteinopathies can be classified on the basis of their miRNA profiles. Our results identified both miRNAs distinct to the anatomy, disease type and pathology, and miRNAs consistently dysregulated within single proteinopathies and across neurodegeneration in general. Our results also highlight the necessity to minimize the variability between studies. These findings showcase the need for more transcriptomic research on infrequently occurring NDDs, and the need for the standardization of research techniques and platforms utilized across labs and diseases.
Original languageEnglish
Article number1034
Issue number6
Publication statusPublished - 1 Jun 2022


  • amyloidopathies
  • miRNAs
  • neurodegenerative diseases
  • synucleinopathies
  • tauopathies

Cite this